Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4926-4935

  Lan, Lin ^a,b   Gorke, Sebastian ^a   Rau, Sibylle J ^a   Zeisel, Mirjam B ^c,d   Hildt, Eberhard ^a,e   Himmelsbach, Kiyoshi ^a,e   Carvajal Yepes, Monica ^a,e   Huber, Roman ^a   Wakita, Takaji ^f   Schmitt Graeff, Annette ^a   Royer, Cathy ^c,d   Blum, Hubert E ^a   Fischer, Richard ^a   Baumert, Thomas F ^c,d,g  

^a UNIVERSITY OF FREIBURG   (Germany)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c INSERM   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e UNIVERSITY OF KIEL   (Germany)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CELL PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS PROTEIN; CORE PROTEIN; E1 PROTEIN, HEPATITIS C VIRUS; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; TNFSF10 PROTEIN, HUMAN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; ELECTROPORATION; HEPATITIS C; HEPATOMA CELL; HOST CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; LIVER CELL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SENSITIZATION; TISSUE CULTURE; AUTOCRINE EFFECT; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; ENZYMOLOGY; GENE DELETION; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

APOPTOSIS; AUTOCRINE COMMUNICATION; CARCINOMA, HEPATOCELLULAR; CASPASE 9; CELL LINE, TUMOR; CELLS, CULTURED; GENE DELETION; HEPACIVIRUS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MITOCHONDRIA; TNF-RELATED APOPTOSIS-INDUCING LIGAND; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 58149286583     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4926     Document Type: Article

References (60)

1. Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345: 41-52.
2. Bartenschlager, R. 2006. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. Curr. Opin. Microbiol. 9: 416-422. (Pubitemid 44108723)
3. Dustin, L. B., and C. M. Rice. 2007. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 25: 71-99.
4. Calabrese, F., P. Pontisso, E. Pettenazzo, L. Benvegnu, A. Vario, L. Chemello, A. Alberti, and M. Valente. 2000. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 31: 1153-1159. (Pubitemid 30233241)
5. Volkmann, X., U. Fischer, M. J. Bahr, M. Ott, F. Lehner, M. Macfarlane, G. M. Cohen, M. P. Manns, K. Schulze-Osthoff, and H. Bantel. 2007. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology 46: 1498-1508. (Pubitemid 350155532)
6. LeBlanc, H. N., and A. Ashkenazi. 2003. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10: 66-75.
7. Lawrence, D., Z. Shahrokh, S. Marsters, K. Achilles, D. Shih, B. Mounho, K. Hillan, K. Totpal, L. DeForge, P. Schow, et al. 2001. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat. Med. 7: 383-385. (Pubitemid 32298514)
8. Zylberberg, H., A. C. Rimaniol, S. Pol, A. Masson, D. De Groote, P. Berthelot, J. F. Bach, C. Brechot, and F. Zavala. 1999. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J. Hepatol. 30: 185-191. (Pubitemid 29071178)
9. Kumar, S. 2007. Caspase function in programmed cell death. Cell Death Differ. 14: 32-43. (Pubitemid 44911892)
10. Irusta, P. M., Y. B. Chen, and J. M. Hardwick. 2003. Viral modulators of cell death provide new links to old pathways. Curr. Opin. Cell Biol. 15: 700-705.
11. Kakkar, P., and B. K. Singh. 2007. Mitochondria: a hub of redox activities and cellular distress control. Mol. Cell. Biochem. 305: 235-253. (Pubitemid 47517185)
12. Armstrong, J. S. 2006. The role of the mitochondrial permeability transition in cell death. Mitochondrion 6: 225-234. (Pubitemid 44567384)
13. Fischer, R., T. Baumert, and H. E. Blum. 2007. Hepatitis C virus infection and apoptosis. World J. Gastroenterol. 13: 4865-4872.
14. Der, S. D., Y. L. Yang, C. Weissmann, and B. R. Williams. 1997. A doublestranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 3279-3283.
15. Yoneyama, M., and T. Fujita. 2007. Function of RIG-I-like receptors in antiviral innate immunity. J. Biol. Chem. 282: 15315-15318. (Pubitemid 47093255)
16. Zhang, P., and C. E. Samuel. 2007. Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J. Virol. 81: 8192-8200. (Pubitemid 47101505)
17. Zeisel, M. B., and T. F. Baumert. 2006. Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research. J. Hepatol. 44: 436-439.
18. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309: 623-626. (Pubitemid 41033648)
19. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11: 791-796. (Pubitemid 41021213)
20. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102: 9294-9299. (Pubitemid 40923557)
21. Codran, A., C. Royer, D. Jaeck, M. Bastien-Valle, T. F. Baumert, M. P. Kieny, C. A. Pereira, and J. P. Martin. 2006. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J. Gen. Virol. 87: 2583-2593. (Pubitemid 44241234)
22. Zeisel, M. B., G. Koutsoudakis, E. K. Schnober, A. Haberstroh, H. E. Blum, F. L. Cosset, T. Wakita, D. Jaeck, M. Doffoel, C. Royer, et al. 2007. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46: 1722-1731.
23. Kato, T., T. Date, M. Miyamoto, A. Furusaka, K. Tokushige, M. Mizokami, and T. Wakita. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125: 1808-1817. (Pubitemid 37500445)
24. Pietschmann, T., A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis, E. Steinmann, K. Abid, F. Negro, M. Dreux, F. L. Cosset, and R. Bartenschlager. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103: 7408-7413. (Pubitemid 43727846)
25. Fischer, R., R. Reinehr, T. P. Lu, A. Schonicke, U. Warskulat, H. P. Dienes, and D. Haussinger. 2005. Intercellular communication via gap junctions in activated rat hepatic stellate cells. Gastroenterology 128: 433-448. (Pubitemid 40431095)
26. Pestka, J. M., M. B. Zeisel, E. Blaser, P. Schurmann, B. Bartosch, F. L. Cosset, A. H. Patel, H. Meisel, J. Baumert, S. Viazov, et al. 2007. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc. Natl. Acad. Sci. USA 104: 6025-6030.
27. Burckstummer, T., M. Kriegs, J. Lupberger, E. K. Pauli, S. Schmittel, and E. Hildt. 2006. Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication. FEBS Lett. 580: 575-580. (Pubitemid 43089688)
28. Barth, H., A. Ulsenheimer, G. R. Pape, H. M. Diepolder, M. Hoffmann, C. Neumann-Haefelin, R. Thimme, P. Henneke, R. Klein, G. Paranhos-Baccala, et al. 2005. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood 105: 3605-3614. (Pubitemid 40628207)
29. Steinmann, D., H. Barth, B. Gissler, P. Schurmann, M. I. Adah, J. T. Gerlach, G. R. Pape, E. Depla, D. Jacobs, G. Maertens, et al. 2004. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. J. Virol. 78: 9030-9040. (Pubitemid 39096514)
30. Fischer, R., A. Cariers, R. Reinehr, and D. Haussinger. 2002. Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology 123: 845-861. (Pubitemid 34977091)
31. Chou, A. H., H. F. Tsai, Y. Y. Wu, C. Y. Hu, L. H. Hwang, P. I. Hsu, and P. N. Hsu. 2005. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 174: 2160-2166.
32. Lee, S. H., Y. K. Kim, C. S. Kim, S. K. Seol, J. Kim, S. Cho, Y. L. Song, R. Bartenschlager, and S. K. Jang. 2005. E2 of hepatitis C virus inhibits apoptosis. J. Immunol. 175: 8226-8235.
33. Chiou, H. L., Y. S. Hsieh, M. R. Hsieh, and T. Y. Chen. 2006. HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway. Biochem. Biophys. Res. Commun. 345: 453-458.
34. Sprick, M. R., E. Rieser, H. Stahl, A. Grosse-Wilde, M. A. Weigand, and H. Walczak. 2002. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J. 21: 4520-4530.
35. Wieder, T., F. Essmann, A. Prokop, K. Schmelz, K. Schulze-Osthoff, R. Beyaert, B. Dorken, and P. T. Daniel. 2001. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97: 1378-1387. (Pubitemid 32183762)
36. Tang, D., J. M. Lahti, and V. J. Kidd. 2000. Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J. Biol. Chem. 275: 9303-9307. (Pubitemid 30185152)
37. Oliver, F. J., G. de la Rubia, V. Rolli, M. C. Ruiz-Ruiz, G. de Murcia, and J. M. Murcia. 1998. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J. Biol. Chem. 273: 33533-33539. (Pubitemid 29005737)
38. Hetz, C. A. 2007. ER Stress Signaling and the BCL-2 Family of Proteins: From Adaptation to Irreversible Cellular Damage. Antioxid. Redox. Signal 9: 2345-2356.
39. Ozoren, N., and W. S. El-Deiry. 2002. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Neoplasia 4: 551-557. (Pubitemid 35417080)
40. Strater, J., H. Walczak, T. Pukrop, L. Von Muller, C. Hasel, M. Kornmann, T. Mertens, and P. Moller. 2002. TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology 122: 659-666. (Pubitemid 34173818)
41. Ishikawa, E., M. Nakazawa, M. Yoshinari, and M. Minami. 2005. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice. J. Virol. 79: 7658-7663. (Pubitemid 40756799)
42. Sedger, L. M., D. M. Shows, R. A. Blanton, J. J. Peschon, R. G. Goodwin, D. Cosman, and S. R. Wiley. 1999. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163: 920-926.
43. Mundt, B., F. Kuhnel, L. Zender, Y. Paul, H. Tillmann, C. Trautwein, M. P. Manns, and S. Kubicka. 2003. Involvement of TRAIL and its receptors in viral hepatitis. FASEB J. 17: 94-96.
44. Zhu, H., H. Dong, E. Eksioglu, A. Hemming, M. Cao, J. M. Crawford, D. R. Nelson, and C. Liu. 2007. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133: 1649-1659. (Pubitemid 350029762)
45. Erdtmann, L., N. Franck, H. Lerat, J. Le Seyec, D. Gilot, I. Cannie, P. Gripon, U. Hibner, and C. Guguen-Guillouzo. 2003. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J. Biol. Chem. 278: 18256-18264. (Pubitemid 36799444)
46. Prikhod'ko, E. A., G. G. Prikhod'ko, R. M. Siegel, P. Thompson, M. E. Major, and J. I. Cohen. 2004. The NS3 protein of hepatitis C virus induces caspase-8- mediated apoptosis independent of its protease or helicase activities. Virology 329: 53-67.
47. Nomura-Takigawa, Y., M. Nagano-Fujii, L. Deng, S. Kitazawa, S. Ishido, K. Sada, and H. Hotta. 2006. Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria- mediated apoptosis. J. Gen. Virol. 87: 1935-1945. (Pubitemid 43985876)
48. Nanda, S. K., D. Herion, and T. J. Liang. 2006. The SH3 binding motif of HCV (corrected) NS5A protein interacts with Bin1 and is important for apoptosis and infectivity. Gastroenterology 130: 794-809.
49. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172. (Pubitemid 41509355)
50. Wang, J., W. Tong, X. Zhang, L. Chen, Z. Yi, T. Pan, Y. Hu, L. Xiang, and Z. Yuan. 2006. Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells. FEBS Lett. 580: 4392-4400. (Pubitemid 44118256)
51. Chung, Y. L., M. L. Sheu, and S. H. Yen. 2003. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int. J. Cancer 107: 65-73.
52. Tardif, K. D., G. Waris, and A. Siddiqui. 2005. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 13: 159-163.
53. MacFarlane, M. 2003. TRAIL-induced signalling and apoptosis. Toxicol. Lett. 139: 89-97.
54. Wagner, K. W., E. A. Punnoose, T. Januario, D. A. Lawrence, R. M. Pitti, K. Lancaster, D. Lee, M. von Goetz, S. F. Yee, K. Totpal, et al. 2007. Deathreceptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 13: 1070-1077.
55. Everett, H., and G. McFadden. 1999. Apoptosis: an innate immune response to virus infection. Trends Microbiol. 7: 160-165. (Pubitemid 29229902)
56. Dunn, C., M. Brunetto, G. Reynolds, T. Christophides, P. T. Kennedy, P. Lampertico, A. Das, A. R. Lopes, P. Borrow, K. Williams, et al. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204: 667-680. (Pubitemid 46457088)
57. Liang, X., Y. Liu, Q. Zhang, L. Gao, L. Han, C. Ma, L. Zhang, Y. H. Chen, and W. Sun. 2007. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J. Immunol. 178: 503-510. (Pubitemid 46033634)
58. Zender, L., S. Hutker, B. Mundt, M. Waltemathe, C. Klein, C. Trautwein, N. P. Malek, M. P. Manns, F. Kuhnel, and S. Kubicka. 2005. NFκB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis. Hepatology 41: 280-288. (Pubitemid 40165371)
59. Sato, K., S. Hida, H. Takayanagi, T. Yokochi, N. Kayagaki, K. Takeda, H. Yagita, K. Okumura, N. Tanaka, T. Taniguchi, and K. Ogasawara. 2001. Antiviral response by natural killer cells through TRAIL gene induction by IFN- α/β. Eur. J. Immunol. 31: 3138-3146. (Pubitemid 33100505)
60. Pelli, N., F. Torre, A. Delfino, M. Basso, and A. Picciotto. 2006. Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C. J. Interferon Cytokine Res. 26: 119-123. (Pubitemid 43364049)